L. Alameda

"Do not do" recommendations of the Spanish Society of Anaesthesiology, Critical Care and Pain Therapy. "Commitment to Quality by Scientific Societies" Project.

R. Abascal, L. Q. Gutiérrez, J. Vecino, 2016 .

Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models

S. Wicha, L. Alameda, G. J. de Knegt, 2017, CPT: pharmacometrics & systems pharmacology.

Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.

L. Alameda, S. Ferrer, U. Simonsson, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection

F. Gleeson, J. Vaquero, L. Alameda, 2022, Pharmaceutics.

The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model

L. Alameda, Iñigo Angulo-Barturen, S. Ferrer, 2017, Journal of Pharmacokinetics and Pharmacodynamics.